<DOC>
	<DOCNO>NCT01328730</DOCNO>
	<brief_summary>Sirolimus-eluting stent ( SES ) world-widely used clinical practice treat patient coronary artery disease ( CAD ) . The efficacy safety Cypher SES ( Cordis , MA ) prove several randomized clinical trial . Here investigator design prospective , multicenter , randomize clinical study purpose identify non-inferiority efficacy safety treat CAD patient Firebird 2 SES ( Microport , Shanghai ) , compare Cypher SES .</brief_summary>
	<brief_title>The Real-world Firebird 2 Versus Cypher Sirolimus-eluting Stent Treating Patients With Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>age &gt; 18 year male unpreganant female stenosis &gt; 70 % one major epicardial coronary artery contraindication stent implantation sing informed consent acute myocardial infarction within one week contraindication stent implantation tolerate dual antiplatelet therapy history stent implantation within last oneyear receive brand coronary stent index procedure achievement inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>significant stenosis ( &gt; 70 % lumen stenosis )</keyword>
	<keyword>epicardial coronary artery .</keyword>
</DOC>